Activation of proteases and changes in Na+-K+-ATPase subunits in hearts subjected to ischemia-reperfusion

Journal of Applied Physiology

Volumn 114, Issue 3, 2013, Pages 351-360

  Müller, Alison L ^a   Freed, Darren ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Calpain; Ischemia reperfusion injury; Matrix metalloproteinases; Na+ K+ ATPase; Proteases

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALPAIN; GELATINASE A; PEPTIDE HYDROLASE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; ENZYMOLOGY; HEART; HEART MUSCLE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN SUBUNIT; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; CALPAIN; HEART; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEPTIDE HYDROLASES; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84873435383     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01239.2012     Document Type: Article

References (48)

1. Ali MA, Schulz R. Activation of MMP-2 as a key event in oxidative stress injury to the heart. Front Biosci 14: 699-716, 2009.
2. Ali MA, Stepanko A, Fan X, Holt A, Schulz R. Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity. Biochem Biophys Res Commun 423: 1-5, 2012.
3. Balse E, Steele DF, Abriel H, Coulombe A, Fedida D, Hatem SN. Dynamic of ion channel expression at the plasma membrane of cardiomyocytes. Physiol Rev 92: 1317-1358, 2012.
4. Cheung P, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101: 1833-1839, 2000.
5. Chohan PK, Singh RB, Dhalla NS, Netticadan T. L-arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc Res 69: 152-163, 2006.
6. Clark JMJ, Chang AY. Inhibitors of transfer of amino acids from aminoacyl soluble ribonucleic acid to proteins. J Biol Chem 240: 4734- 4739, 1965.
7. Dhalla NS, Panagia V, Singal PK, Makino N, Dixon IM, Eyolfson DA. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 20: S3-S13, 1998.
8. Dhalla NS, Saini HK, Tappia PS, Sethi R, Mengi SA, Gupta SK. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease. J Cardiovasc Med (Hagerstown) 8: 238-250, 2007.
9. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673, 2000.
10. Elmoselhi AB, Lukas A, Ostadal P, Dhalla NS. Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na-K-ATPase in hearts. Am J Physiol Heart Circ Physiol 285: H1055-H1063, 2003.
11. Fert-Bober J, Leon H, Sawicka J, Basran RS, Devon RM, Schulz R, Sawicki G. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol 103: 431-443, 2008.
12. Fiolet J, Baartscheer A, Schumacher C, Coronel R, Ter Welle H. The change of the free energy of ATP hydrolysis during global ischemia and anoxia in the rat hearts: its possible role in the regulation of transsarcolemmal sodium and potassium gradients. J Mol Cell Cardiol 16: 1023-1036, 1984.
13. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 48: 1014-1022, 1962.
14. Henry PD, Schuchleib R, Davis J, Weiss ES, Sobel BE. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol Heart Circ Physiol 233: H677-H684, 1977.
15. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylaminde gels containing sodium dodecyl sulphate and colpolymerized substrates. Anal Biochem 102: 196-202, 1980.
16. Huang W, Wang Y, Askari A, Zolotarjova N, Ganjeizadeh M. Different sensitivies of the Na-/K-ATPase isoforms to oxidants. Biochim Biophys Acta 1190: 108-114, 1994.
17. Iwamoto H, Miura T, Okamura T, Shirakawa K, Iwatate M, Kawamura S, Tatsuno H, Ikeda Y, Matsuzaki M. Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemic/reperfused rat heart. J Cardiovasc Pharmacol 33: 580-586, 1999.
18. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase- 2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res 85: 413-423, 2010.
19. Kleber A. Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res 52: 442-450, 1983.
20. Kobayashi S, Yoshikawa Y, Sakata S, Takenaka C, Hagihara H, Ohga Y, Abe T, Taniguchi S, Takaki M. Left ventricular mechanoenergetics after hyperpolarized cardioplegic arrest by nicorandil and after depolarized cardioplegic arrest by KCl. Am J Physiol Heart Circ Physiol 287: H1072- H1080, 2004.
21. Lalu MM, Pasini E, Schulze CJ, Ferrari-Vivaldi M, Ferrari-Vivaldi G, Bachetti T, Schulz R. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J 26: 27-35, 2005.
22. Larsen TH, Dalen H, Sommer JR, Boyle R, Lieberman M. Membrane skeleton in cultured chick cardiac myocytes revealed by high resolution immunocytochemistry. Histochem Cell Biol 112: 307-316, 1999.
23. Mani SK, Balasubramanian S, Zavadzkas JA, Jeffords LB, Rivers WT, Zile MR, Mukherjee R, Spinale FG, Kuppuswamy D. Calpain inhibition preserves myocardial structure and function following myocardial infarction. Am J Physiol Heart Circ Physiol 297: H1744-H1751, 2009.
24. Mitani A, Shattock M. Role of Na-activated K channel, Na-K-Cl cotransport, and Na-K pump in [K]e changes during ischemia in rat heart. Am J Physiol Heart Circ Physiol 263: H333-H340, 1992.
25. Müller AL, Dhalla NS. Role of various proteases in cardiac remodeling and progression of heart failure. Heart Fail Rev 17: 395-409, 2011.
26. Müller AL, Freed D, Hryshko LV, Dhalla NS. Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters. Can J Physiol Pharmacol 90: 995-1004, 2012.
27. Müller AL, Hryshko LV, Dhalla NS. Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury. Int J Cardiol. In press.
28. Ostadal P, Elmoselhi AB, Zdobnicka I, Lukas A, Chapman D, Dhalla NS. Ischemia-reperfusion alters gene expression of Na-K-ATPase isoforms in rat heart. Biochem Biophys Res Commun 306: 457-462, 2003.
29. Ostadal P, Elmoselhi AB, Zdobnicka I, Lukas A, Elimban V, Dhalla NS. Role of oxidative stress in ischemia-reperfusion-induced changes in Na-K-ATPase isoform expression in rat heart. Antioxid Redox Signal 6: 914-923, 2004.
30. Rodríguez D, Morrison CJ, Overall CM. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803: 39-54, 2010.
31. Saini HK, Dhalla NS. Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288: H2260-H2270, 2005.
32. Saini HK, Elimban V, Dhalla NS. Attenuation of extracellular ATP response in cardiomyocytes isolated from hearts subjected to ischemiareperfusion. Am J Physiol Heart Circ Physiol 289: H614-H623, 2005.
33. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112: 544- 552, 2005.
34. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47: 211-242, 2007.
35. Schulze CJ, Wang W, Saurez-Pinzon WL, Sawicka J, Sawicka G, Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation 107: 2487-2492, 2003.
36. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102: 11876-11881, 2005.
37. Singh RB, Dandekar SP, Elimban V, Gupta SK, Dhalla NS. Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem 263: 241-256, 2004.
38. Singh RB, Dhalla NS. Ischemia-reperfusion-induced changes in sarcolemma Na-K-ATPase are due to the activation of calpain in the heart. Can J Physiol Pharmacol 88: 388-397, 2010.
39. Singh RB, Elimban V, Dhalla NS. Differences in ischemia- reperfusioninduced endothelial changes in hearts perfused at constant flow and constant pressure. J Appl Physiol 105: 1779-1787, 2008.
40. Singh RB, Hryshko L, Freed D, Dhalla NS. Activation of proteolytic enzymes and depression of the sarcolemma Na-K-ATPase in ischemiareperfused heart may be mediated through oxidative stress. Can J Physiol Pharmacol 90: 249-260, 2012.
41. Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 43: 429-436, 2007.
42. Sybers HD, Myre CD, Myre MV. X-ray microanalysis of calcium in ischemic myocardium: a new method of rapid freezing. Scan Electron Microsc 769-776, 1983.
43. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol Heart Circ Physiol 277: H584-H594, 1999.
44. Terkildsen JR, Crampin EJ, Smith NP. The balance between inactivation and activation of the Na-K- pump underlies the triphasic accumulation of K- during myocardial ischemia. Am J Physiol Heart Circ Physiol 293: H3036-H3045, 2007.
45. Tsuji T, Ohga Y, Yoshikawa Y, Sakata S, Abe T, Tabayashi N, Kobayashi S, Kohzuki H, Yoshida KI, Suga H, Kitamura S, Taniguchi S, Takaki M. Rat cardiac contractile dysfunction induced by Ca2- overload: possible link to the proteolysis of fodrin. Am J Physiol Heart Circ Physiol 281: H1286-H1294, 2001.
46. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106: 1543- 1549, 2002.
47. Yoshikawa Y, Hagihara H, Ohga Y, Nakajima-Takenaka C, Murata KY, Taniguchi S, Takaki M. Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics. Am J Physiol Heart Circ Physiol 288: H1690-H1698, 2005.
48. Ytrehus K, Myklebust R, Olsen R, Mjos OD. Ultrastructural changes induced in the isolated rat heart by enzymatically generated oxygen radicals. J Mol Cell Cardiol 19: 379-389, 1987.